A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 78
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ASCCP
Long Form : American Society for Colposcopy and Cervical Pathology
No. Year Title Co-occurring Abbreviation
2020 Evaluation of PCR-Reverse Dot Blot Human Papillomavirus Genotyping Test in Predicting Residual/Recurrent CIN 2+ in Posttreatment Patients in China. CIR, HR, TCT, TP
2019 Does the 'equal management of equal risks' model cause overtreatment in patients with positive cervical cytology results for ASCUS/non-HPV16/18 oncogenic types? ASCUS, HPV
2019 PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort. HPV, HR-HPV, NPV, PCR, TCT
2018 Human Papillomavirus Testing by Veterans Administration Women's Health Providers: Are They Adhering to Guidelines? HPV, USPSTF, VA, VA
2018 Immediate biopsy of cervical cytology-negative and non-HPV-16/18 oncogenic types positive patients. ---
2018 Improving the Accuracy of a Clinical Decision Support System for Cervical Cancer Screening and Surveillance. CDSS, EMR
2018 The Effect of the 2012 ASCCP Consensus Guideline for Abnormal Cervical Cytology on Resident Colposcopy Training. ---
2017 Accuracy of Cervical Visual Inspection with Acetic Acid Guide for 4-Quadrant Random Cervical Biopsies by General Practitioners in Women with Abnormal Pap Smears V4B
2017 ASCCP Colposcopy Standards: Colposcopy Quality Improvement Recommendations for the United States. ---
10  2017 ASCCP Colposcopy Standards: How Do We Perform Colposcopy? Implications for Establishing Standards. ---
11  2017 ASCCP Colposcopy Standards: Risk-Based Colposcopy Practice. ---
12  2017 Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States. US
13  2017 Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines. AGC, ASC-H, ASCUS, CIN, HPV, HSIL, LSIL, NILM
14  2017 The Clinical Significance of Endometrial Cells Detected on Pap Testing: The Impact of Revisions to the 3rd Edition of the Bethesda System for Reporting Cervical Cytology. BEC, Pap
15  2016 Practice Bulletin No. 157 Summary: Cervical Cancer Screening and Prevention. ACS, ASCP, FDA, HPV, SGO, USPSTF
16  2016 Practice Bulletin No. 157: Cervical Cancer Screening and Prevention. ACS, ASCP, FDA, HPV, SGO, USPSTF
17  2016 Practice Bulletin No. 168 Summary: Cervical Cancer Screening and Prevention. ACS, ASCP, FDA, HPV, SGO, USPSTF
18  2016 Practice Bulletin No. 168: Cervical Cancer Screening and Prevention. ACS, ASCP, FDA, HPV, SGO, USPSTF
19  2016 [Investigation of human papillomavirus prevalence in women in Eskisehir, Turkey by Pap smear, hybrid capture 2 test and consensus real-time polymerase chain reaction and typing with pyrosequencing method]. CC, FDA, HC2, HPV, RT-PCR
20  2015 Colposcopy Requirement of Papanicolaou Smear after Atypical Squamous Cells of Undetermined Significance (ASC-US) by Follow-up Protocol in an Urban Gynaecology Clinic, a Retrospective Study in Thailand. ASCUS, CIN, COC, HPV
21  2015 Current Cervical Carcinoma Screening Guidelines. ACOG, ACS, ASCP, HPV
22  2015 Have the 2006 American Society for Colposcopy and Cervical Pathology (ASCCP) guidelines enriched the yield of high-grade squamous intraepithelial lesions? ---
23  2015 Making Sense of Cervical Cancer Screening Guidelines and Recommendations. ACS, ASCP, CIN2, HPV
24  2013 Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening. CC, CIN, HCII, HPV, HR, LCT
25  2013 The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. CAP, HPV, LAST
26  2012 ACOG Practice Bulletin Number 131: Screening for cervical cancer. ACS, ASCP
27  2012 American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. ACS, ASCP, HPV
28  2012 The influence of ASCCP guideline changes on family medicine residency colposcopy training. ---
29  2010 Comparison of the clinical significance of the Papanicolaou test interpretations LSIL cannot rule out HSIL and ASC-H. SIL
30  2010 Follow-up for cervical abnormalities in a managed care plan, 1999-2004. ---
31  2010 The 2006 consensus guidelines for the management of women with abnormal cervical screening tests: challenges remain. ---
32  2009 Interpretability of excisional biopsies of the cervix: cone biopsy and loop excision. CKC, LEEP
33  2008 Assessment of follow-up for low-grade cytological abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000-2005. LSIL
34  2008 Home study course: winter 2008. ACCME
35  2007 Home study course: fall 2007. ACCME
36  2007 Home study course: spring 2007. ACCME
37  2007 Home Study Course: summer 2007. ACCME
38  2006 ASC-H in Pap test--definitive categorization of cytomorphological spectrum. HPVT
39  2006 Home study course: fall 2006. ACCME
40  2006 Home Study Course: Spring 2006. ACCME
41  2006 Home Study Course: summer 2006. ACCME
42  2006 Home Study Course: Winter 2006. ACCME
43  2006 [Evaluation of clinical management strategies for atypical squamous cells of undetermined significance in cervical cytology]. ASCUS, HSIL
44  2005 Home Study Course: Fall 2005. ACCME
45  2005 Home study course: summer 2005. ACCME
46  2004 Guidelines for screening and treatment of cervical disease in the adolescent. ACS
47  2004 High-risk human papillomavirus detection: a split-sample comparison of hybrid capture and chromogenic in situ hybridization. CISH, HC, HPV
48  2004 Hom study course: winter 2004. ACCME
49  2004 Home study course: Fall 2004. ACCME
50  2004 Home study course: spring 2004. ACCME
51  2004 Home study course: Summer 2004. ACCME
52  2004 Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. HPV
53  2003 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. CIN
54  2003 2001 Consensus guidelines for the management of women with cervical intraepithelial neoplasia. CIN
55  2003 Home study course: Fall 2003. ACCME
56  2003 Home study course: summer 2003. ACCME
57  2003 Participants at the ASCCP 2000 Biennial Meeting adhere to published guidelines in their management of atypical squamous cells and atypical glandular cells on pap test. AGUS, ASCUS, CIN, SIL
58  2003 Spring 2003. ACCME
59  2003 The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors. ASCUS, CIN, HPV, LSIL
60  2003 Winter 2003. ACCME
61  2002 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. ASC, ASC-US, HPV, HSIL
62  2002 ASCCP patient management guidelines: Pap test specimen adequacy and quality indicators. Pap
63  2002 Fall 2002. ACCME
64  2002 Home study course: Spring 2002. ACCME
65  2002 Home study course: winter 2002. ACCME
66  2001 Home study course: autumn 2001. ACCME
67  2001 Home study course: spring 2001. ACCME
68  2001 Home study course: summer 2001. ACCME
69  2001 Home study course: winter 2001. ACCME
70  2000 Home study course: autumn 2000. ACCME
71  2000 Home study course: spring 2000. ACCME
72  2000 Home study course: summer 2000. ACCME
73  2000 Home study course: winter 2000. ACCME
74  1999 Home study course: autumn 1999. ---
75  1999 Home study course: spring 1999. ACCME
76  1998 Home study course: summer 1998. ACCME
77  1997 Home study course: autumn 1997. ACCME
78  1997 Home study course: spring 1997. ---